Serum glial fibrillary acidic protein (GFAP) is a longitudinal indicator of disease progression in MS while neurofilament light chain (NfL) associates with therapy response in patients under B-cell depleting therapy Pascal Benkert , Aleksandra Maleska Maceski , Sabine Schadelin , Eline Willemse , Stephanie Meier , Lester Melie-Garcia , Alessandro Cagol , Riccardo Galbusera , Suvitha Subramaniam , Johannes Lorscheider , Bettina Fischer-Barnicol , Lutz Achtnichts , Oliver Findling , Patrice Lalive , Claire Bridel , Stefanie Mueller , Caroline Pot , Amandine Mathias , Renaud Du Pasquier , Anke Salmen , Robert Hoepner , Andrew Chan , Giulio Disanto , Chiara Zecca , Annette Orleth , Marcus DSouza , Ozgur Yaldizli , Tobias Derfuss , Johanna Oechtering , Claudio Gobbi , Michael Khalil , Ahmed Abdelhak , Jorge R. Oksenberg , Marco Hermesdorf , Klaus Berger , Heinz Wiendl , Fredrik Piehl , David Conen , Andreas Buser , Ludwig Kappos , Cristina Granziera , David Leppert , Jens Kuhle MULTIPLE SCLEROSIS JOURNAL(2023)
AI 理解论文
溯源树
样例